Lassen, U., Henrik Jensen, L., Sorensen, M., Rohrberg, K. S., Ujmajuridze, Z., & Jakobsen, A. (2011). A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas. Acta Oncologica, 50(3), 448–454. https://doi.org/10.3109/0284186X.2010.500300